SEI INVESTMENTS CO financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data SEI INVESTMENTS CO files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	1,402	1,527	1,624	1,650	1,684	1,918	1,991	1,920	2,125	2,297
Gross profit	435	461	508	533	520	645	644	557	699	808
Selling and marketing							188	171	174	174
General and administrative		63.8	65.6	72.2	74	91.9	168	132	148	181
Operating income	376	397	442	460	446	553	476	425	552	627
Interest expense	0.53	0.78	0.65	0.63	0.61	0.56	0.75	0.58	0.56	0.61
Interest income	4.32	7.06	13.4	16.6	6.57	3.65	13.3	41	48.9	39.9
Pre-tax income	508	557	614	631	569	694	609	595	747	916
Income tax	175	153	108	130	121	147	134	132	166	199
Net income to minority interests								0	0	2.25
Net income	334	404	506	501	447	547	475	462	581	715
EBITDA	402	424	471
EPS, basic	2.07	2.56	3.23	3.31	3.05	3.87	3.49	3.49	4.47	5.76
EPS, diluted	2.03	2.49	3.14	3.24	3.00	3.81	3.46	3.46	4.41	5.63
Shares, diluted (weighted)	164	162	161	155	149	143	137	134	132	127
Dividend per share	0.54	0.58	0.63	0.68	0.72	0.77	0.83	0.89	0.95	1.01

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	696	744	755	841	785	831	853	835	840	400
Receivables	228	283	315	340	385	442	457	501	568	710
Other current assets	27.6	31.2	36.7	32.3	38.7	43.6	48.7	54.5	60.3	66.7
Total current assets	1,038	1,140	1,191	1,305	1,301	1,404	1,453	1,478	1,552	1,273
Property, plant and equipment	146	146	146	161	189	179	181	171	160	150
Lease right-of-use assets				42.8	38.4	33.6	25	22.5	28.9	26.4
Goodwill	0	53	64.5	64.5	64.5	117	116	137	170	355
Intangible assets	0	28.6	31.7	28	24.3	68.8	55.5	82.4	77.4	368
Long-term investments			112	117	105	130	128	155
Other non-current assets	15.5	18.9	34.2	30.2	32.3	24.9	33.7	37	47.2	60.1
Total assets	1,637	1,853	1,972	2,151	2,167	2,355	2,384	2,520	2,685
Accounts payable	5.97	5.27	10.9	4.42	7.77	10.3	13.3	10.6	13.1	5.4
Accrued liabilities	241	265	280	273	300	324	359	319	348	360
Deferred revenue	2.88	4.72	5.15	7.19	1.09	9.72	14.9	15.4	12	13.3
Short-term debt										0
Total current liabilities	249	275	296	294	317	356	398	353	381	387
Long-term debt										0
Lease liabilities				38.5	34.1	27.6	18.8	17.2	24.2	19.9
Other non-current liabilities	0	12.4	24.2	24.1	20.1	20.9	12.3	17.1	26.9	23.6
Total liabilities	334	377	379	413	427	494	430	388	432	800
Total debt										0
Paid-in capital	955	1,028	1,107	1,159	1,190	1,247	1,307	1,405	1,540	1,679
Retained earnings	384	467	518	602	565	633	694	763	758	792
Other comprehensive income	-38	-19.9	-33	-23.5	-16.8	-19.8	-49	-37	-47	-24.5
Shareholders' equity		1,477	1,593	1,739	1,740	1,861	1,954	2,132	2,252	2,448
Minority interests									0	12
Total equity	1,303	1,477	1,593	1,739	1,740	1,861	1,954	2,132	2,252	2,460
Total liabilities and equity	1,637	1,853	1,972	2,151	2,167	2,355	2,384	2,520	2,685	3,260
Shares outstanding	159	157	154	150	143	138	134	131	127	122

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	334	404	506	501	447	547	475	462	581	718
Depreciation and amortization	26.4	27.3	28.8
Stock-based compensation	16	36.4	23.8	24.6	27	41.5	39.4	31.3	58.6	53.6
Deferred income tax	0.62	-21.8	3.73	-2.6	-0.98	-7.83	-46.5	-33.5	-13.8	59.2
Change in receivables	-4.81	-52.7	-32.7	-25.5
Change in payables	1.46	-0.91	5.65	-6.5	3.34	0.25	2.97	-2.67	2.46	-7.86
Cash from operations	434	460	588	545	489	633	566	447	622	608
Capital expenditures	-31.4	-25.5	-29.1	-43.1	-54.4	-26.5	-39.2	-24.8	-32.2	-22.6
Acquisitions	0	-80.2	-5.79	0	0	-80.2	0	-56.4	-29	-302
Purchases of investments	-73.2	-69.5	-203	-175	-143	-216	-178	-143	-177	-158
Sales and maturities of investments	54.1	65.8	168	171	155	195	161	121	145	124
Cash from investing	-81.6	-172	-123	-78.2	-67.5	-165	-89.8	-142	-117	-399
Stock issued	48.3	53.6	88	60.9	49.4	55.2	58.2	101	126	144
Share buybacks	-292	-248	-407	-346	-427	-408	-345	-309	-500	-628
Dividends paid	-84.7	-88.9	-94.3	-101	-104	-106	-110	-115	-120	-124
Cash from financing	-329	-254	-444	-387	-482	-422	-437	-331	-494	-589
Exchange rate effect	-9.92	14.6	-11	6.19	4.13	-1.87	-17.5	7.48	-5.45	11.3
Net change in cash	14	48.6	10.3	86.5	-56.8	44	21.6	-18.4	5.2	-370
Free cash flow	403	434	559	502	434	607	527	422	590	585
Interest paid	0.53	0.7	0.81	0.49	0.61	0.55	0.82	0.7	0.56	0.58
Income taxes paid	157	165	110	139	122	154	193	146	185	170

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $105.65 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	36.0%	Gross profit / revenue.
Operating margin	28.9%	Operating income / revenue.
Pre-tax margin	37.2%	Pre-tax income / revenue.
Net margin	28.8%	Net income / revenue.
FCF margin	28.0%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	29.1%	Cash from operations / revenue.
Effective tax rate	21.6%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	28.3%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on invested capital (ROIC)	26.0%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Stock-based pay / revenue	2.3%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	1.0%	Capital expenditures / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	8.1%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	4.9%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	6.4%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	15.5%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	7.9%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	9.2%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	13.7%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	9.7%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	7.1%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	23.1%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	14.6%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	9.8%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	27.7%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	17.6%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	13.4%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-2.4%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	2.4%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	4.5%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-0.9%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	3.5%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	6.1%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	6.3%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	6.8%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	7.0%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	8.7%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	7.8%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	7.1%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-3.5%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-2.6%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-3.1%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	5.06x	Current assets / current liabilities.
Quick ratio	4.44x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	1.49x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.01x	Total debt / shareholders' equity. Not shown when equity is negative.
Net debt	-$362.7M	Total debt - cash - short-term investments. Negative means more cash than debt.
Interest coverage	518x	Operating income / interest expense.
Working capital	$1.08B	Current assets - current liabilities.
Tangible book value	$2.11B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Fixed asset turnover	16.1x	Revenue / average property, plant and equipment.
Receivables turnover	3.13x	Revenue / average receivables.
Days sales outstanding	117 days	365 x average receivables / revenue.
FCF conversion	97.2%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	3.5%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$5.73	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$19.87	Revenue / diluted weighted shares.
FCF per share	$5.57	Free cash flow / diluted weighted shares.
Operating cash flow per share	$5.77	Cash from operations / diluted weighted shares.
Book value per share	$20.83	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$17.59	Tangible book value / shares outstanding.
Cash per share	$3.30	(Cash + short-term investments) / shares outstanding.
Buybacks / FCF	82.3%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$12.68B	Share price x shares outstanding.
Enterprise value	$12.32B	Market cap + total debt - cash - short-term investments.
P/E	17.9x	Market cap / net income. Only when net income is positive.
P/S	5.18x	Market cap / revenue.
P/B	5.07x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	6.01x	Market cap / tangible book value, when positive.
P/FCF	18.5x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	17.8x	Market cap / cash from operations, when positive.
EV/Sales	5.03x	Enterprise value / revenue.
EV/EBIT	17.4x	Enterprise value / operating income, when both are positive.
EV/FCF	17.9x	Enterprise value / free cash flow, when both are positive.
FCF yield	5.4%	Free cash flow / market cap.
Earnings yield	5.6%	Net income / market cap (the inverse of P/E).
Shareholder yield	4.5%	(Dividends paid + share buybacks) / market cap.
PEG	1.02x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was SEI INVESTMENTS CO's revenue in fiscal 2025?

SEI INVESTMENTS CO reported revenue of $2.30B for fiscal 2025, 8.1% higher than the year before.

Was SEI INVESTMENTS CO profitable in fiscal 2025?

Yes. Net income was $715.3M, a net margin of 31.1%.

How much free cash flow did SEI INVESTMENTS CO generate in fiscal 2025?

Cash from operations of $607.7M minus capital expenditures of $22.6M left free cash flow of $585.0M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to SEI INVESTMENTS CO